| Daniel Schabel, | |
|
100 Gilbert Dr, Alabaster, AL 35007-8867 | |
| (205) 259-3991 | |
| Not Available |
| Full Name | Daniel Schabel |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 27 Years |
| Location | 100 Gilbert Dr, Alabaster, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437566460 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PTH2951 (Alabama) | Primary |
| Provider Name | Donahoo Physical Therapy Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1023435674 PECOS PAC ID: 4486877081 Enrollment ID: O20140529001666 |
News Archive
Patients with irritable bowel syndrome are at no greater risk of having polyps, colon cancer or inflammatory bowel diseases than healthy people undergoing colonoscopies, according to new research published in the American Journal of Gastroenterology.
Cheese fondue is an icon of Swiss cuisine and a dinner party staple. While it may seem like a simple dish, getting the texture right can be a challenge for optimal mouthfeel, dipping and flavor release.
Awarepoint Corporation, the leading provider of real-time location system (RTLS) solutions for healthcare, announced today that it has secured $27 million in Series F financing. New investor Kleiner Perkins Caufield & Byers (KPCB) led the round of financing, which also included participation from new investor Top Tier Capital Partners, and existing investors Cardinal Partners, Venrock, and Jafco Ventures.
Cancer therapies targeting specific molecular subtypes of the disease allow physicians to tailor treatment to a patient's individual molecular profile. But scientists are finding that in many types of cancer the molecular subtypes are more varied than previously thought and contain further genetic alterations that can affect a patient's response to therapy.
Advaxis, Inc.,, a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has completed a pre-IND (Investigational New Drug) meeting with the FDA on August 10 to discuss the development plan for ADXS-PSA, a construct for the treatment of prostate cancer.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniel Schabel, 100 Gilbert Dr, Alabaster, AL 35007-8867 Ph: (205) 259-3991 | Daniel Schabel, 100 Gilbert Dr, Alabaster, AL 35007-8867 Ph: (205) 259-3991 |
News Archive
Patients with irritable bowel syndrome are at no greater risk of having polyps, colon cancer or inflammatory bowel diseases than healthy people undergoing colonoscopies, according to new research published in the American Journal of Gastroenterology.
Cheese fondue is an icon of Swiss cuisine and a dinner party staple. While it may seem like a simple dish, getting the texture right can be a challenge for optimal mouthfeel, dipping and flavor release.
Awarepoint Corporation, the leading provider of real-time location system (RTLS) solutions for healthcare, announced today that it has secured $27 million in Series F financing. New investor Kleiner Perkins Caufield & Byers (KPCB) led the round of financing, which also included participation from new investor Top Tier Capital Partners, and existing investors Cardinal Partners, Venrock, and Jafco Ventures.
Cancer therapies targeting specific molecular subtypes of the disease allow physicians to tailor treatment to a patient's individual molecular profile. But scientists are finding that in many types of cancer the molecular subtypes are more varied than previously thought and contain further genetic alterations that can affect a patient's response to therapy.
Advaxis, Inc.,, a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has completed a pre-IND (Investigational New Drug) meeting with the FDA on August 10 to discuss the development plan for ADXS-PSA, a construct for the treatment of prostate cancer.
› Verified 4 days ago
Lisa Anne Vogel, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 750 Colonial Promenade Pkwy, Suite 4400, Alabaster, AL 35007 Phone: 205-358-1040 Fax: 205-358-1041 | |
Patrick Ogg, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 100 Gilbert Dr, Alabaster, AL 35007 Phone: 205-259-3991 Fax: 205-621-2212 | |
Madeline Grace Lee, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 831 1st St N Ste B, Alabaster, AL 35007 Phone: 205-358-9138 Fax: 205-803-6642 | |
Shelby Grace Troyer, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 831 1st St N, Suite B, Alabaster, AL 35007 Phone: 205-358-9138 Fax: 205-358-9139 | |
Paige Marie Trammell, DPT, OCS, MTC Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 831 1st St N Ste B, Alabaster, AL 35007 Phone: 205-358-9138 Fax: 205-358-9139 | |
Morgan Gibson, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 750 Colonial Promenade Pkwy Ste 4400, Alabaster, AL 35007 Phone: 205-358-1040 Fax: 205-358-1041 | |
Encore Rehabilitation, Inc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 831 1st St N Ste B, Alabaster, AL 35007 Phone: 205-605-9005 Fax: 205-624-8092 |